Head and Neck Diseases by Alexandros G.Sfakianakis: Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?

Πέμπτη 11 Ιανουαρίου 2018

Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?

http:--linkinghub.elsevier.com-ihub-imag

Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?

Eur J Cancer. 2017 12;87:205-208

Authors: Strik H, Keber U, Hammoud WA, Riera-Knorrenschild J, Carl B, Dodel R, Pagenstecher A, Neubauer A

PMID: 29050806 [PubMed - indexed for MEDLINE]

http://ift.tt/2mrod4j

Head and Neck Diseases by Alexandros G.Sfakianakis

Πέμπτη 11 Ιανουαρίου 2018

Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου